Company Overview of Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism in the United States. The company’s product candidates include AG-221, a potent inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations; and AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations. Its product candidates also comprise AG-348, an oral small molecule and activator of the pyruvate kinase-R enzyme used for the treatment of patients with PK...
38 Sidney Street
Cambridge, MA 02139
Founded in 2007
Key Executives for Agios Pharmaceuticals, Inc.
Chief Executive Officer, President and Director
Total Annual Compensation: $500.0K
Principal Financial Officer and Senior Vice President of Finance
Total Annual Compensation: $309.0K
Chief Medical Officer
Total Annual Compensation: $371.4K
Chief Scientific Officer
Total Annual Compensation: $387.3K
Compensation as of Fiscal Year 2014.
Agios Pharmaceuticals, Inc. Key Developments
Agios Pharmaceuticals, Inc. Appoints Steve Hoerter as Chief Commercial Officer, Effective February 16, 2016
Feb 8 16
Agios Pharmaceuticals, Inc. announced the appointment of Steve Hoerter to the newly created position of chief commercial officer, effective February 16, 2016. Mr. Hoerter has more than 20 years of global pharmaceutical and biotechnology experience, most recently having served as executive vice president and chief commercial officer at Clovis Oncology, Inc. as well as previous senior commercial roles at Genentech and Roche.
Perry Karsen to Resign from the Board of Directors of Agios Pharmaceuticals, Inc., Effective March 1, 2016
Feb 5 16
On February 1, 2016, Perry Karsen notified Agios Pharmaceuticals, Inc. of his decision to resign from the board of directors of the company, effective March 1, 2016.
Agios Pharmaceuticals, Inc. Presents at The LEERINK Partners 5th Annual Global Healthcare Conference, Feb-10-2016 11:30 AM
Jan 19 16
Agios Pharmaceuticals, Inc. Presents at The LEERINK Partners 5th Annual Global Healthcare Conference, Feb-10-2016 11:30 AM. Venue: The Waldorf Astoria, New York, New York, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|